Nuveen Asset Management, LLC Travere Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,743,190 shares of TVTX stock, worth $39.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,743,190

Previous 1,832,103 4.85%

Holding current value

$39.9 Million

Previous $25.6 Million 18.47%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.65 - $19.85 $1.21 Million - $1.76 Million	-88,913 Reduced 4.85%	1,743,190 $30.4 Million
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $8.64 Million - $16.6 Million	1,094,465 Added 148.37%	1,832,103 $25.6 Million
Q2 2024 Aug 09, 2024	BUY	$5.26 - $8.28 $32,927 - $51,832	6,260 Added 0.86%	737,638 $6.06 Million
Q1 2024 May 13, 2024	BUY	$7.18 - $9.82 $1.77 Million - $2.43 Million	247,050 Added 51.01%	731,378 $5.64 Million
Q4 2023 Feb 14, 2024	SELL	$5.44 - $9.5 $1.2 Million - $2.1 Million	-220,975 Reduced 31.33%	484,328 $4.35 Million
Q3 2023 Nov 14, 2023	SELL	$7.64 - $17.25 $1.42 Million - $3.2 Million	-185,474 Reduced 20.82%	705,303 $6.31 Million
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $8.62 Million - $12.7 Million	563,124 Added 171.87%	890,777 $13.7 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $2.56 Million - $3.29 Million	143,585 Added 78.01%	327,653 $7.37 Million
Q4 2022 Feb 14, 2023	SELL	$18.47 - $26.14 $4.16 Million - $5.89 Million	-225,420 Reduced 55.05%	184,068 $4.54 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $629,314 - $786,437	-27,469 Reduced 6.29%	409,488 $10.1 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $607,008 - $869,929	28,988 Added 7.11%	436,957 $10.8 Million
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $232,676 - $301,563	-9,855 Reduced 2.36%	407,969 $10.1 Million
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $1.43 Million - $1.83 Million	-58,721 Reduced 12.32%	417,824 $10.3 Million
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $2.55 Million - $4.93 Million	-196,772 Reduced 29.22%	476,545 $11.8 Million
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $2.74 Million - $5.12 Million	-193,909 Reduced 22.36%	673,317 $16.6 Million
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $2.48 Million - $3.37 Million	106,204 Added 13.96%	867,226 $21.4 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $14.6 Million - $21.2 Million	761,022 New	761,022 $18.8 Million

Others Institutions Holding TVTX

# of Institutions

213

Shares Held

94M

Call Options Held

1.2M

Put Options Held

778K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.47B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Travere Therapeutics, Inc. Transaction History